Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.2765 EUR -0.36%
Market Cap: 32m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Balance Sheet

Balance Sheet Decomposition
Gensight Biologics SA

Current Assets 13m
Cash & Short-Term Investments 6.9m
Receivables 1.3m
Other Current Assets 4.7m
Non-Current Assets 2m
Long-Term Investments 519k
PP&E 1.4m
Intangibles 66k
Current Liabilities 16.9m
Accounts Payable 4.8m
Accrued Liabilities 1.6m
Other Current Liabilities 10.5m
Non-Current Liabilities 23m
Long-Term Debt 16m
Other Non-Current Liabilities 6.9m

Balance Sheet
Gensight Biologics SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
11
30
54
55
26
19
38
44
11
2
Cash
1
0
0
0
0
0
0
0
11
2
Cash Equivalents
9
30
54
55
26
19
38
44
0
0
Short-Term Investments
1
0
0
0
0
0
0
0
0
0
Total Receivables
2
4
3
5
5
6
4
5
4
2
Accounts Receivables
1
0
0
0
0
1
0
1
0
0
Other Receivables
1
4
3
5
5
6
4
4
4
2
Other Current Assets
0
1
1
1
3
2
2
4
9
2
Total Current Assets
14
35
58
61
35
28
44
53
23
7
PP&E Net
0
1
1
1
1
4
3
3
2
2
PP&E Gross
0
1
1
1
1
4
3
3
2
2
Accumulated Depreciation
0
0
0
1
1
2
3
4
5
4
Intangible Assets
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
0
0
0
0
0
1
1
1
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
Total Assets
15
N/A
36
+145%
59
+63%
62
+5%
37
-41%
32
-12%
47
+46%
57
+20%
26
-54%
9
-65%
Liabilities
Accounts Payable
2
5
2
2
8
7
8
12
8
6
Accrued Liabilities
1
1
1
2
2
2
3
2
4
2
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
1
3
5
2
17
Other Current Liabilities
1
1
0
0
0
2
4
3
1
0
Total Current Liabilities
4
6
3
4
10
12
17
22
15
25
Long-Term Debt
1
1
3
3
3
10
16
12
15
6
Other Liabilities
0
0
0
0
0
0
2
6
11
8
Total Liabilities
4
N/A
7
+65%
6
-16%
7
+23%
13
+82%
22
+68%
36
+62%
41
+14%
41
+1%
40
-3%
Equity
Common Stock
0
0
0
1
1
1
1
1
1
2
Retained Earnings
9
21
38
58
89
118
142
166
198
223
Additional Paid In Capital
19
50
91
112
112
128
153
181
181
191
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
11
N/A
29
+177%
53
+82%
55
+3%
24
-57%
11
-56%
12
+12%
16
+36%
15
N/A
31
-101%
Total Liabilities & Equity
15
N/A
36
+145%
59
+63%
62
+5%
37
-41%
32
-12%
47
+46%
57
+20%
26
-54%
9
-65%
Shares Outstanding
Common Shares Outstanding
14
14
19
24
24
33
41
46
46
65

See Also

Discover More